Clayton Alison
School of Historical and Philosophical Studies, University of Melbourne, Parkville3010, Australia.
J Sex Marital Ther. 2023;49(1):88-95. doi: 10.1080/0092623X.2022.2070565. Epub 2022 May 9.
This commentary compares two recently published informed consent recommendations for gender dysphoria. One key difference identified is in their assessment of the strength of the evidence base for the gender affirming treatment model. An evaluation of both authors' citations supports the claims of a weak evidence base for the use of puberty blockers and gender affirming hormonal treatments in youth with gender dysphoria. This commentary then reflects on the implications of this. In particular, it asks whether it would be best practice to provide gender affirming treatments for youth only under clinical research conditions, rather than as routine clinical practice.
本评论比较了最近发表的两项关于性别焦虑症的知情同意建议。所确定的一个关键差异在于它们对性别肯定治疗模式证据基础强度的评估。对两位作者引用文献的评估支持了这样的说法，即对于患有性别焦虑症的青少年使用青春期阻滞剂和性别肯定激素治疗的证据基础薄弱。本评论随后思考了这一情况的影响。特别是，它提出对于青少年，仅在临床研究条件下而非作为常规临床实践提供性别肯定治疗是否是最佳做法。
